Tag: Pharmaceutical

John Murphy
United States

John Murphy Named President and CEO of AAM

Brings years of industry, policy, and association leadership experience WASHINGTON, DC (September 25, 2024) – The Association for Accessible Medicines Board of Directors today announced the appointment of John A. Murphy, III to be the association’s President and Chief Executive Officer. Mr. Murphy will join AAM in October. Mr. Murphy most recently served as the Chief Policy Officer at the Biotechnology Innovation Organization, where he … Continue reading John Murphy Named President and CEO of AAM

Impact Newswire
Acadia
United States

Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

– Ms. Owen Adams brings over 25 years of pharmaceutical industry experience including senior commercial leadership roles with Bristol Myers Squibb and Johnson & Johnson SAN DIEGO, Sep. 23, 2024 – Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board of Directors. “We are excited to welcome Catherine Owen … Continue reading Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

Impact Newswire
Novotech
United States

Novotech Earns Great Place to Work® Certification in the United States

BOSTON – Novotech, a global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been certified as a Great Place to Work® in the United States. This award reflects Novotech’s commitment to fostering a flexible, inclusive, and innovative work environment where employees feel supported and empowered to contribute to the future of medical research. “Our employees are the heart of Novotech, … Continue reading Novotech Earns Great Place to Work® Certification in the United States

Impact Newswire
Alentis
Europe

Alentis Appoints Jonathan Freve CFO

Jon brings more than 25 years of financial experience in the biotech sector BASEL, Switzerland – Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today that Jonathan (Jon) Freve has been appointed Chief Financial Officer effective immediately. Roberto Iacone, CEO of Alentis said, “Jon has a proven track record in successful IPOs, secondary offerings and … Continue reading Alentis Appoints Jonathan Freve CFO

Impact Newswire
pfizer
United States

Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare

Tuesday, August 27, 2024 – 06:45am NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll , a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S. The new, end-to-end experience will support the millions of Americans affected annually by common illnesses like migraine, COVID-19 or flu, and those seeking to protect themselves with adult vaccinations. … Continue reading Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare

Impact Newswire
OM1
United States

OM1 Appoints Catherine Richards as President

Richards to lead cross-functional teams, enhancing OM1’s impact on healthcare transformation through advanced data solutions BOSTON – OM1, the leader in real-world evidence generation and insights for life sciences, proudly announces the appointment of Catherine Richards, PhD, MPH, as its first President. Richards will oversee the Product, Engineering, Clinical Informatics, Client Services, Data Science, and Research teams. Her leadership will be pivotal in advancing OM1’s strategy, innovation, and … Continue reading OM1 Appoints Catherine Richards as President

Impact Newswire
Merck
United States

Merck Completes Acquisition of EyeBio

Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret™, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration, as well as preclinical candidates RAHWAY, N.J. – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). EyeBio is now a wholly-owned subsidiary of Merck. “The … Continue reading Merck Completes Acquisition of EyeBio

Impact Newswire
Fresenius Kabi
United States

Arunesh Verma Joins Fresenius Kabi USA as President

Verma succeeds John Ducker who will retire after 35 years with Fresenius LAKE ZURICH, Ill. – Fresenius Kabi announced today that Arunesh Verma has joined the company as president of Fresenius Kabi USA and a member of the company’s global Executive Leadership Team, reporting to Pierluigi Antonelli, CEO of Fresenius Kabi. “At the same time, I want to thank John Ducker for his outstanding leadership and achievement … Continue reading Arunesh Verma Joins Fresenius Kabi USA as President

Impact Newswire
United States

Selkirk Pharma Appoints Colleen Dixon as New CEO

SPOKANE, Wash. – Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of Selkirk Pharma and its Chairman and … Continue reading Selkirk Pharma Appoints Colleen Dixon as New CEO

Impact Newswire